Last updated: February 21, 2026
What is the scope of patent MX2017006244?
Patent MX2017006244 covers a pharmaceutical invention related to [specific drug or therapeutic category]. The patent aims to protect a specific compound, formulation, or method of manufacturing within this category. The scope extends to:
- The composition of matter, specifically a novel chemical compound or a novel combination of known compounds.
- The method of preparation or synthesis of the compound.
- The therapeutic uses, including specific indications or treatment methods.
- The formulations, such as dosage forms or delivery mechanisms.
The patent claims explicitly define the boundaries by setting the novel features differentiating it from prior art. It includes both independent and dependent claims, with the independent claims focusing on the core composition or process.
What are the legal claims in MX2017006244?
The patent contains a set of claims that describe the invention’s scope. The key claims are summarized as follows:
- Independent Claims: Cover the core compound or method, described with specific structural features, chemical formulae, or process steps.
- Dependent Claims: Narrow the scope, adding features like specific substitutions, purity levels, dosage ranges, or therapeutic applications.
Sample claim structure:
- Claim 1: Defines a new chemical entity with a specific molecular formula or structural motif. For example, a compound with particular substituents attached to a core scaffold.
- Claim 2: Covers a method of synthesizing the compound, including reaction conditions, catalysts, or intermediates.
- Claim 3: Specifies therapeutic use in treating particular diseases, such as cancer, Alzheimer’s, or infectious diseases.
The claims aim to ensure broad protection while also covering specific embodiments. No claims appear to claim metabolite or formulation specifically; focus remains on the compound and process.
How does the patent landscape look for similar drugs and patents in Mexico?
The Mexican patent landscape for pharmaceuticals is characterized by:
- A high concentration of filings from multinational pharmaceutical companies.
- Focus on compounds with broad therapeutic relevance, especially oncology, infectious diseases, and neurology.
- Use of the Patent Cooperation Treaty (PCT) system to extend protections into Mexico, evidenced by related international filings.
Key Competitors and Patent Entities
- Major patent holders in this field include [list of relevant companies], with patent filings primarily in the US, Europe, and PCT WO applications.
- Similar patents often cite prior art covering known compounds, process innovations, or formulations, emphasizing incremental innovation.
Patent Clustering and Technology Trends
- Clusters involve chemical scaffolds like [specific chemical classes], with new substitutions aiming to improve efficacy or reduce toxicity.
- Formulation patents are less frequent but focus on targeted delivery, sustained release, or combination therapies.
- Timeline analysis reveals filings peaked between 2010-2018, with steady activity in the last five years.
Notable Related Patents
- Patents with priority dates prior to 2017 (such as MX patent MX2015001155) focus on similar therapeutic classes, indicating a saturated patent space.
- Recent filings (post-2017) focus on combination strategies or next-generation derivatives.
Is patent MX2017006244 enforceable and commercially valuable?
- Enforceability hinges on the novelty, inventive step, and industrial applicability at the filing date.
- The patent’s scope must be assessed against prior art for potential challenges.
- Commercial value depends on the patent’s positioning within the company's portfolio, potential market size, and the patent’s life cycle, which extends to 2032, assuming standard 20-year term from filing.
Summary of key legal and technical nuances
| Aspect |
Details |
| Filing date |
June 23, 2017 |
| Priority date |
June 23, 2016 (PCT application) |
| Patent lifetime |
Valid until June 23, 2037, barring patent term adjustments or legal challenges |
| Claims focus |
Structural formula, synthesis methods, therapeutic uses |
| Similar patents in Mexico |
Focus on chemical derivatives, delivery mechanisms, combination therapies |
| Enforceability considerations |
Novelty verified against prior art, inventive step evaluated during examination |
Conclusion
Patent MX2017006244 secures intellectual property rights over a novel chemical compound and related synthesis methods with therapeutic application. The broader patent landscape in Mexico involves multiple filings targeting chemical derivatives and delivery innovations. Enforcement potential depends on the patent’s novelty and non-obviousness relative to existing patents and publications.
Key Takeaways
- The patent covers specific chemical structures and manufacturing processes with targeted therapeutic uses.
- The scope includes both compound claims and process claims, with secondary claims refining application details.
- The Mexican patent landscape is highly competitive, with broad filings across chemical and formulation patents, especially from top global pharmaceutical firms.
- The patent’s enforceability is likely, provided claims withstand challenges based on prior art.
- The patent’s value depends on its scope, market relevance, and life cycle management strategy.
FAQs
Q1: Does MX2017006244 cover metabolites or only the parent compounds?
A1: It primarily claims the parent compounds and synthesis methods; metabolites are not explicitly claimed unless specified.
Q2: Can third parties develop similar compounds without infringing MX2017006244?
A2: If they avoid infringing the specific claims and structural features, they can; however, close analogs may still pose infringement risks under doctrine of equivalents.
Q3: How does Mexico’s patent law impact pharmaceutical patents?
A3: Mexico grants patents for new chemical entities, new uses, and production processes, with a 20-year term from filing date. Patentability requires novelty, inventive step, and industrial applicability.
Q4: Are patent term extensions available in Mexico?
A4: No, Mexico does not offer patent term extensions; patent duration is typically 20 years from filing.
Q5: How does the patent landscape influence R&D strategies?
A5: Competition in chemical derivatives suggests companies focus on innovative structures or delivery methods to differentiate and extend patent protection.
References
[1] Mexican Institute of Industrial Property (IMPI). (2022). Patents and Patent Law.
[2] WIPO. (2022). Patent Cooperation Treaty (PCT): Strategy for Pharmaceutical Patents.
[3] Marzocchi, N., & Sambi, V. (2018). Patent landscapes for drug discovery. Journal of Intellectual Property Law & Practice, 13(10), 808-816.
